SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2026-08-07 21:09
Tx date 2026-07-30
$TELO
Telo Genomics Corp.
Price, John
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+1,000,000 vol
1,000,000
Filed 2026-08-07 21:07
Tx date 2026-01-30
$TELO
Telo Genomics Corp.
Price, John
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2026-08-07 21:07
Tx date 2026-03-06
$TELO
Telo Genomics Corp.
Price, John
5 - Senior Officer of Issuer
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption

+200,000 vol
200,000
Filed 2026-08-07 21:05
Tx date 2026-01-30
$TELO
Telo Genomics Corp.
Price, John
5 - Senior Officer of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2026-08-07 21:05
Tx date 2026-03-06
$TELO
Telo Genomics Corp.
Price, John
5 - Senior Officer of Issuer
Direct Ownership
Convertible Debentures
16 - Acquisition or disposition under a prospectus exemption

+$10,000 vol
$10,000
Filed 2026-08-07 21:04
Tx date 2026-01-30
$TELO
Telo Genomics Corp.
Price, John
5 - Senior Officer of Issuer
Direct Ownership
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
Filed 2026-08-05 18:29
Tx date 2025-04-04
$TELO
Telo Genomics Corp.
Farlinger, John Allen
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
350,000
Filed 2026-08-05 18:25
Tx date 2026-07-30
$TELO
Telo Genomics Corp.
Farlinger, John Allen
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+500,000 vol
4,550,000
Filed 2026-06-25 19:20
Tx date 2025-04-04
$TELO
Telo Genomics Corp.
Farlinger, John Allen
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2026-06-25 19:21
Tx date 2026-03-18
$TELO
Telo Genomics Corp.
Farlinger, John Allen
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+3,700,000 vol
3,700,000
Filed 2026-06-25 19:20
Tx date 2025-04-04
$TELO
Telo Genomics Corp.
Farlinger, John Allen
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2026-03-12 18:03
Tx date 2026-03-06
$TELO
Telo Genomics Corp.
Farlinger, John Allen
4 - Director of Issuer
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption

+700,000 vol
700,000
Filed 2026-03-12 18:01
Tx date 2025-04-04
$TELO
Telo Genomics Corp.
Farlinger, John Allen
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2026-03-12 18:01
Tx date 2026-03-06
$TELO
Telo Genomics Corp.
Farlinger, John Allen
4 - Director of Issuer
Direct Ownership
Convertible Debentures
16 - Acquisition or disposition under a prospectus exemption

+$35,000 vol
$35,000
Filed 2026-03-12 18:00
Tx date 2025-04-04
$TELO
Telo Genomics Corp.
Farlinger, John Allen
4 - Director of Issuer
Direct Ownership
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
Filed 2026-03-06 16:59
Tx date 2025-04-04
$TELO
Telo Genomics Corp.
Farlinger, John Allen
4 - Director of Issuer
Holder: RRSP (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
30,530
Filed 2025-03-11 18:06
Tx date 2025-03-06
$TELO
Telo Genomics Corp.
Ross, Chris
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$22,500
+150,000 vol
$0.15 each
250,000
Filed 2025-03-11 18:04
Tx date 2025-03-06
$TELO
Telo Genomics Corp.
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$52,500
+350,000 vol
$0.15 each
650,000
Filed 2025-03-11 18:03
Tx date 2025-03-06
$TELO
Telo Genomics Corp.
Mai, Sabine
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$75,000
+500,000 vol
$0.15 each
1,280,752
Filed 2025-03-11 18:01
Tx date 2025-03-06
$TELO
Telo Genomics Corp.
Baechler, Guido
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$150,000
+1,000,000 vol
$0.15 each
1,700,000